Mail: info@sterilize.it  – Linkedin: sterilize.it


  • Member Area
  • Registration
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us

An innovative way to thermally sterilize Hyaluronic Acid Pre-filled Syringes

Several reports on degradation of Hyaluronic Acid (HA) involving microwaves, UV or γ-rays have been published. Rheological studies also show that Hyaluronic Acid (HA) solutions degrade at high temperature: viscosity of the solutions decreases in time as a function of temperature. Therefore, the thermal sterilization treatment of Hyaluronic Acid (HA) solutions represents a great challenge. An optimized moist-heat sterilization cycle can minimize product degradation (and change of molecular weight) maintaining the required viscosity for the specific application.

KEYWORDS: Dynamic viscosity determination, Peak cycle, Counterpressure treatment, Moist-heat sterilization, Sodium Hyaluronate, Pre-filled Syringes (PFS).

 

1. SODIUM HYALURONATE PFS

The Sodium Hyaluronate used to prepare the batch had an average molecular weight equal to 1.6 x 106 Dalton. The formulations were prepared by hydrating the polysaccharide in a physiological phosphate buffer solution for 12 hours at 50°C. The bulk preparations were divided in pre-filled syringes. Prefilled syringes with Hyaluronate Sodium provided by IBSA.

2. PROCESS SELECTED

Samples were treated using an Air over Steam autoclave (Fedegari FOA); this process equipment works with counterpressure in the chamber to balance pressure increase inside the syringes during the sterilization and to
avoid the risk of plunger movement.
The air initially contained in the chamber is not extracted – as in a pure saturated steam cycle – but it is only “controlled” by increasing or decreasing its quantity (i.e. the pressure) during the heating/sterilization/cooling
phase according to the characteristics of the load. The pressure of chamber air increases as it heats (with the relation of the absolute sterilization and cycle start temperatures).
The total pressure in the chamber during the sterilization phase is given by the partial pressure of the heated air plus the partial steam pressure; the final pressure in the chamber will be therefore much higher than the one obtained with pure saturated steam autoclaves.

3. COUNTER-PRESSURE

The counter-pressure inside the autoclave was adjusted by setting the air pressure correction coefficient at 1.2. This value is a little higher than the standard value (1.08) to avoid plunger expulsion. At 121°C, 115°C and 130°C, the pressure of the vessel was 3.56 abs, 3.18 abs, and 4.25 abs, respectively. These values were calculated by using the counter-pressure equation (equation 1) and also verifying the results on Thema 4 in the final phase data section.

[…]

related articles

  • Risk considerations for the installation of a new pharmaceutical facility…
  • Current USP Perspectives on Sterilization & Sterility Assurance
  • Principles of sterilization – From A to Z
  • Product Stability Issues
  • Practical issues on PFS sterilization: an analysis of critical aspects
  • author: Bernuzzi Maria Luisa and Gori Andrea

The content you requested is only available for registered users. Please, register to download the file.
It's fast and free. Register here.
If you are a registered user enter your e-mail address and password to log in.

• Download
PDF File

0
0
0
0

related articles

  • Importance of risk assessment for aseptic transfer in pharmaceutical compounding
  • How does moist heat inactivate microorganisms?
  • EMA Annex 1 Draft Revision Comments from Industry Experts
  • Highlights on F0
  • Key factors in the choice and development of a cleaning strategy

related articles

  • Risk considerations for the installation of a new pharmaceutical facility…
  • Current USP Perspectives on Sterilization & Sterility Assurance
  • Principles of sterilization – From A to Z
  • Product Stability Issues
  • Practical issues on PFS sterilization: an analysis of critical aspects

0 Commenti

Leave Reply Annulla risposta

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Search
  • Enter your keyword

  • Processes

  • Applications

  • Author

Recent articles
  • A History of Isolator and Containment Technology, Part 5: Development and use of sterilising agents with associated devices
  • A history of isolator and containment technology Part 4: Transfer devices
  • A history of isolator and containment technology Part 3: Non-flexible film isolators including RABS
  • A history of isolator and containment technology Part 2: Flexible film isolators
  • Importance of risk assessment for aseptic transfer in pharmaceutical compounding

Practical issues on PFS sterilization: an analysis of critical aspects

What is a sterilization autoclave?

Scroll
Contact

Mail: info@sterilize.it
Linkedin: sterilize.it

Member Area
Accesso
Password persa
Process
  • Aseptic processing
  • Cleaning
  • Chemical bio-decontamination
  • Moist-heat sterilization
  • Sterilization
Application
  • Blood bags
  • Environmental Monitoring
  • Food
  • General
  • Hyaluronic Acid
  • Other applications
  • Package Integrity
  • Pharma – Liquids
  • Pharmaceutical compounding
  • Pre-filled syringes (PFSs)
  • Robotics
  • Sealed containers
  • Validation
Subscribe to newsletter

Subscribe to our newsletter to stay informed about our news and info.

Join here

© Copyright 2020 Sterilize.it. All rights reserved. Privacy Policy e Cookie

Fedegari Autoclavi SpA | Albuzzano - SS 235 Km 8, CAP. 27010 (PV) | REA: PV- 130961 | P.IVA IT00303010185 | PEC: amministrazione@pec.fedegari.com | Capitale Sociale Versato 5.000.000,00 € i.v.